Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

United Therapeutics buy Royal Bank of Canada

Start price
€485.00
18:45 / 50%
Target price
€615.51
07.07.27
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 07.07.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time.
Performance without dividends (%)
Name 1w
United Therapeutics -
iShares Core DAX® 4.367%
iShares Nasdaq 100 -0.294%
iShares Nikkei 225® -0.471%
iShares S&P 500 1.267%

Comments by Royal_Bank_of_Canada for this prediction

In the thread United Therapeutics diskutieren
Prediction Buy
Perf. (%) -
Target price 615.507
Change
Ends at 07.07.27

United Therapeutics (UTHR) had its price target raised by Royal Bank Of Canada from $701.00 to $704.00. They now have an "outperform" rating on the stock.
Ratings data for UTHR provided by MarketBeat

Stopped prediction by Royal_Bank_of_Canada for United Therapeutics

buy
United Therapeutics

Start price
Target price
Perf. (%)
€485.40
07.05.26
€596.27
07.05.27
-0.08%
16:49

buy
United Therapeutics

Start price
Target price
Perf. (%)
€426.90
26.02.26
€544.04
26.02.27
13.61%
16:49

buy
United Therapeutics

Start price
Target price
Perf. (%)
€388.80
30.10.25
-
30.10.26
24.74%
16:49

buy
United Therapeutics

Start price
Target price
Perf. (%)
€364.40
26.09.25
€487.63
26.09.26
33.10%
16:49